Reports link GLP-1 medications like Ozempic and Mounjaro to vision loss, prompting concerns over their safety.

A new study adds to a growing body of research suggesting a potential link between popular GLP-1 medications like Ozempic and vision loss.

A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name Ozempic — may help reduce not only alcohol cravings, but the amount of alcohol ...

Administered as a once-weekly subcutaneous injection, Ozempic not only helps control blood glucose levels but also reduces ...

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

PATIENTS taking blockbuster diabetes and weight loss drugs are waking up with vision loss, researchers warn. Some reported ...

CBS News Miami investigates the financial hurdles surrounding these medications and explores alternatives that may offer a ...

The popular weight-loss drugs known as GLP-1 receptor agonists, which were originally meant to treat diabetes, surged in ...

Mounjaro vs. Ozempic: Which Is Better for Weight Loss? This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re ...

There are no studies documenting the percentage of doctors taking the drugs. But physicians “are a good litmus test for drugs ...

Two of the most recommended meds nowadays that may aid in reducing weight are Mounjaro and Ozempic. But which one is better? Join us as we embark on a Mounjaro vs. Ozempic efficacy combat to ...

Some Ozempic users are losing their vision - but scientists don’t know why - There’s no direct link between vision loss and ...